Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-25-010567
Filing Date
2025-02-07
Accepted
2025-02-07 16:21:40
Documents
1
Period of Report
2025-02-05

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm255864-8_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm255864-8_4seq1.xml 4 3948
  Complete submission text file 0001104659-25-010567.txt   5623
Mailing Address 5005 MCCONNELL AVE LOS ANGELES CA 90066
Business Address 5005 MCCONNELL AVE LOS ANGELES CA 90066 310-665-2928
Armata Pharmaceuticals, Inc. (Issuer) CIK: 0000921114 (see all company filings)

EIN.: 911549568 | State of Incorp.: WA | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O ARIAD PHARMACEUTICALS 26 LANDSDOWNE STREET CAMBRIDGE MA 02139
Business Address
Schlesinger Sarah J. (Reporting) CIK: 0001579873 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37544 | Film No.: 25602080